Support for business
Business support during lockdown and beyond
During this challenging and uncertain time it is important to know that increased support is available to help businesses deal with the impacts of Covid-19. This support will be available for the duration of the lockdown and beyond.
The Government has put together a COVID-19 Wage Subsidy to support businesses that face laying off staff or reducing their hours because of COVID-19. Employers, contractors, sole traders and self-employed people may qualify to get the wage subsidy of up to $585 per employee per week for up to 12 weeks. For the most up-to-date information and to apply, head to www.workandincome.govt.nz.
Taranaki’s Regional Business Partner, Venture Taranaki, has also ramped up its support services to work directly with business owners and managers in our region. In addition to a range of advisory services, the team are developing a range of online resources and communications to provide businesses with facts, guidance and support. Any South Taranaki enterprise feeling the impacts of the Covid-19 restrictions is encouraged to make contact with Venture Taranaki via email@example.com or by calling (06) 759 5150.
Professional Services Grants for Small-Medium Enterprises
To support our district's small-medium enterprises (SMEs - those with fewer than 50 staff) affected by the impacts of COVID-19, STDC has teamed up with Venture Taranaki to make available a $400 grant, giving access to much-needed professional services advice and support.
SMEs that use one of the professional advice partners will receive an additional $400 of support, thanks to the partners’ own contribution of time; providing them with a total of up to $800 of professional services advice. Those SMEs that wish to use other service providers will still be eligible to access the $400 grant through Venture Taranaki.
The support enables South Taranaki SMEs to access advice including legal, human resource management, financial and business continuity as they navigate the impacts of Covid-19.